Control of herpetic stromal keratitis using CTLA4Ig fusion protein

Clinical Immunology and Immunopathology

Volumn 86, Issue 1, 1998, Pages 88-94

  Gangappa, Shivaprakash ^a   Manickan, Elanchezhiyan ^a   Rouse, Barry T ^a,b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Costimulation; Immunopathology; Stromal keratitis

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS; HISTOPATHOLOGY; IMMUNOMODULATION; IMMUNOTHERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0031963484     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4460     Document Type: Article

References (25)

1. Hyndiuk R. A., Glasser D. B. Herpes simplex keratitis. Infections of the Eye: Diagnosis and Management. 1986;Little, Brown, Boston. p. 343-368.
2. Metcalf J. F., Kaufman H. E. Herpetic stromal keratitis - Evidence for cell mediated immunopathogenesis. Annu. J. Ophthalmol. 82:1976;827-834.
3. Dawson C. R., Togni B. Herpes simplex eye infections - Clinical manifestations, pathogenesis and management. Surv. Ophthalmol. 21:1976;121-135.
4. Doymaz M. Z., Rouse B. T. Herpetic stromal keratitis: An immunopathological disease mediated by CD4+ T lymphocytes. Invest. Ophthalmol. Vis. Sci. 33:1992;2165-2173.
5. Avery A. C., Zhoa Z., Rodriguez A., Bikoff E. K., Soheitian M., Foster C. S., Cantor H. Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide. Nature. 376:1995;431-434.
6. Rouse B. T. Virus-induced immunopathology. Adv. Virus Res. 47:1996;353-376.
7. Niemialtowski M. G., Rouse B. T. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J. Immunol. 149:1992;3035-3039.
8. Hendricks R. L., Tumpey T. M., Finnegan A. IFNγ and IL-2 are protective in the skin but pathologic in the corneas of HSV-infected mice. J. Immunol. 149:1992;3023-3034.
9. Babu J. S., Kanangat S., Rouse B. T. T cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis. J. Immunol. 154:1995;4822-4829.
10. Linsley P. S. Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecular-4 receptors during T cell activation? J. Exp. Med. 182:1995;289-292.
11. Bluestone J. A. New perspectives of CD-28-B7 mediated T cell costimulation. Immunity. 2:1995;555-559.
12. Sharpe A. H. Costimulatory signals and viral immunity. Semin. Virol. 7:1996;103-111.
13. Khoury S. J., Azalin E., Chandraker A., Turka L. A., Linsley P. S., Sayegh M. H., Hancock W. W. CD28-B7 costimulatory blockade by CTLA4Ig prevent actively induced EAE and inhibits Th1 but spares Th2 cytokines in the central nervous system. J. Immunol. 155:1995;4521-4524.
14. Sayegh M. H., Akalin E., Hancock W. W., Russell M. E., Carpenter C. B., Linsley P. S., Turka L. A. CD28-B7 blockade after alloantigenic challengein vivo. J. Exp. Med. 181:1995;1869-1874.
15. Manickan E. R., Rouse J. D., Yu Z., Wire W. S., Rouse B. T. Genetic immunization against herpes simplex virus proliferation is mediated by CD4 T lymphocytes. J. Immunol. 155:1995;259-265.
16. Banks T. A., Jenkins F. J., Kanangat S., Nair S., Dasgupta S., Foster C. M., Rouse B. T. Vaccination with the immediate-early protein ICP47 of herpes virus specific lymphoproliferation, but fails to protect against lethal challenge. Virology. 200:1994;236-245.
17. Babu J. S., Thomas J., Kanangat S., Morrison L. A., Knipe D. M., Rouse B. T. Requirement of viral replication for induction of ocular immunopathology by herpes simplex virus. J. Virol. 70:1996;101-107.
18. Finkelman F. D., Katona I. M., Mosmann T. R., Coffman R. L. IFN-γ regulates the isotypes of Ig secreted duringin vivo. J. Immunol. 140:1988;1022-1027.
19. Tang Q., Chen W., Hendricks R. L. Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. J. Immunol. 158:1997;1275-1283.
20. Brubaker J. O., Thompson C. M., Morrison L. A., Knipe D. M., Siber G. R., Finberg R. W. Th1 associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus. J. Immunol. 157:1996;1598-1604.
21. Arima T., Rehman A., Hickey W. F., Flye M. W. Inhibition by CTL4 Ig of experimental allergic encephalomyelitis. J. Immunol. 156:1996;4916-4924.
22. Knoerzer D. B., Karr R. W., Schwartz B. D., Mengle-Gaw L. J. Collagen-induced arthritis in the BB rat: Prevention of disease by treatment with CTLA4Ig. J. Clin. Invest. 96:1996;987-993.
23. Finck C. X., Linsley P. S., Wolsy D. Treatment of murine herpes with CTLA4Ig. Science. 265:1994;1225-1227.
24. Thomas J., Gangappa S., Kanangat S., Rouse B. T. On the essential involvement of neutrophils in the immunopathological disease herpetic stromal keratitis. J. Immunol. 158:1997;1383-1391.
25. Roizman B., Sears A. Inquiring into mechanisms of herpes simplex virus latency. Annu. Rev. Microbiol. 41:1987;543-571.